Shopping Cart 0
Cart Subtotal
AED 0

GeoVax Labs Inc (GOVX) - Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

GeoVax Labs Inc (GOVX)-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

GeoVax Labs Inc (GeoVax) is a clinical-stage biotech company that develops human vaccines for human immunodeficiency virus (HIV), cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company's vaccine development programs focus on HIV, Zika virus and hemorrhagic fever viruses (Ebola, Marburg, Lassa fever) and for cancer immunotherapy. Its advanced vaccines under development act against the clade B and clade C subtype of the HIV virus. GeoVax developed its proprietary vaccine technology in collaboration with the U.S. National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Emory University. GeoVax is headquartered in Smyrna, Georgia, the US.

GeoVax Labs Inc Key Recent Developments

May 22,2019: GeoVax to conduct partnering meetings during BIO International Convention

May 15,2019: GeoVax to present unique technology at New York Academy of Sciences Vaccine Conference

May 14,2019: GeoVax reports 2019 first quarter financial results and highlights Corporate Development Progress

May 14,2019: GeoVax Labs announces 2019 first quarter financial results

Mar 27,2019: GeoVax reports 2018 year-end financial results

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

GeoVax Labs Inc-Key Facts

GeoVax Labs Inc-Key Employees

GeoVax Labs Inc-Key Employee Biographies

GeoVax Labs Inc-Major Products and Services

GeoVax Labs Inc-History

GeoVax Labs Inc-Company Statement

GeoVax Labs Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

GeoVax Labs Inc-Business Description

GeoVax Labs Inc-Corporate Strategy

GeoVax Labs Inc-SWOT Analysis

SWOT Analysis-Overview

GeoVax Labs Inc-Strengths

GeoVax Labs Inc-Weaknesses

GeoVax Labs Inc-Opportunities

GeoVax Labs Inc-Threats

GeoVax Labs Inc-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

GeoVax Labs Inc, Recent Deals Summary

Section 4-Company's Recent Developments

May 22, 2019: GeoVax to conduct partnering meetings during BIO International Convention

May 15, 2019: GeoVax to present unique technology at New York Academy of Sciences Vaccine Conference

May 14, 2019: GeoVax reports 2019 first quarter financial results and highlights Corporate Development Progress

May 14, 2019: GeoVax Labs announces 2019 first quarter financial results

Mar 27, 2019: GeoVax reports 2018 year-end financial results

Mar 11, 2019: GeoVax provides product development and corporate update

Jan 22, 2019: GeoVax to Present at the 2019 ASM Biothreats Conference

Sep 12, 2018: Geovax to report vaccine development progress at the 12th vaccine congress in Budapest

Aug 29, 2018: GeoVax Strengthens Scientific Staff and Expertise

Aug 14, 2018: GeoVax names David Dodd as Chairman, President and Chief Executive Officer

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

GeoVax Labs Inc, Key Facts

GeoVax Labs Inc, Key Employees

GeoVax Labs Inc, Key Employee Biographies

GeoVax Labs Inc, Major Products and Services

GeoVax Labs Inc, History

GeoVax Labs Inc, Subsidiaries

GeoVax Labs Inc, Key Competitors

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

GeoVax Labs Inc, Recent Deals Summary

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

GeoVax Labs Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Johnson & Johnson

Novavax Inc

Sanofi

Inovio Pharmaceuticals Inc

Merck & Co Inc

Profectus BioSciences Inc

NewLink Genetics Corp

GlaxoSmithKline AG

Protein Sciences Corp

Company Profile

Company Profile Title

GeoVax Labs Inc (GOVX)-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

Highlights

GeoVax Labs Inc (GeoVax) is a clinical-stage biotech company that develops human vaccines for human immunodeficiency virus (HIV), cancer and other infectious diseases using Modified Vaccinia Ankara Virus-Like Particle (MVA-VLP) vaccine platform. The company's vaccine development programs focus on HIV, Zika virus and hemorrhagic fever viruses (Ebola, Marburg, Lassa fever) and for cancer immunotherapy. Its advanced vaccines under development act against the clade B and clade C subtype of the HIV virus. GeoVax developed its proprietary vaccine technology in collaboration with the U.S. National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Emory University. GeoVax is headquartered in Smyrna, Georgia, the US.

GeoVax Labs Inc Key Recent Developments

May 22,2019: GeoVax to conduct partnering meetings during BIO International Convention

May 15,2019: GeoVax to present unique technology at New York Academy of Sciences Vaccine Conference

May 14,2019: GeoVax reports 2019 first quarter financial results and highlights Corporate Development Progress

May 14,2019: GeoVax Labs announces 2019 first quarter financial results

Mar 27,2019: GeoVax reports 2018 year-end financial results

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

GeoVax Labs Inc-Key Facts

GeoVax Labs Inc-Key Employees

GeoVax Labs Inc-Key Employee Biographies

GeoVax Labs Inc-Major Products and Services

GeoVax Labs Inc-History

GeoVax Labs Inc-Company Statement

GeoVax Labs Inc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

GeoVax Labs Inc-Business Description

GeoVax Labs Inc-Corporate Strategy

GeoVax Labs Inc-SWOT Analysis

SWOT Analysis-Overview

GeoVax Labs Inc-Strengths

GeoVax Labs Inc-Weaknesses

GeoVax Labs Inc-Opportunities

GeoVax Labs Inc-Threats

GeoVax Labs Inc-Key Competitors

Section 3-Company's Lifesciences Financial Deals and Alliances

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

GeoVax Labs Inc, Recent Deals Summary

Section 4-Company's Recent Developments

May 22, 2019: GeoVax to conduct partnering meetings during BIO International Convention

May 15, 2019: GeoVax to present unique technology at New York Academy of Sciences Vaccine Conference

May 14, 2019: GeoVax reports 2019 first quarter financial results and highlights Corporate Development Progress

May 14, 2019: GeoVax Labs announces 2019 first quarter financial results

Mar 27, 2019: GeoVax reports 2018 year-end financial results

Mar 11, 2019: GeoVax provides product development and corporate update

Jan 22, 2019: GeoVax to Present at the 2019 ASM Biothreats Conference

Sep 12, 2018: Geovax to report vaccine development progress at the 12th vaccine congress in Budapest

Aug 29, 2018: GeoVax Strengthens Scientific Staff and Expertise

Aug 14, 2018: GeoVax names David Dodd as Chairman, President and Chief Executive Officer

Section 5-Appendix

Methodology

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

GeoVax Labs Inc, Key Facts

GeoVax Labs Inc, Key Employees

GeoVax Labs Inc, Key Employee Biographies

GeoVax Labs Inc, Major Products and Services

GeoVax Labs Inc, History

GeoVax Labs Inc, Subsidiaries

GeoVax Labs Inc, Key Competitors

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

GeoVax Labs Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

GeoVax Labs Inc, Recent Deals Summary

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

GeoVax Labs Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.


Companies

Johnson & Johnson

Novavax Inc

Sanofi

Inovio Pharmaceuticals Inc

Merck & Co Inc

Profectus BioSciences Inc

NewLink Genetics Corp

GlaxoSmithKline AG

Protein Sciences Corp